Clinical Trial Update: Perillyl Alcohol in Treating Patients With Refractory Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for perillyl alcohol in patients with refractory cancer is reported. The study includes lymphoma and protocol-specified adult soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Perillyl Alcohol (perillyl alcohol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED